Literature DB >> 26230240

Functionally Relevant Cut Point for Isometric Quadriceps Muscle Strength in Chronic Respiratory Disease.

Jane L Canavan1, Matthew Maddocks1,2, Claire M Nolan1, Sarah E Jones1, Samantha S C Kon1,3, Amy L Clark1, Michael I Polkey1, William D-C Man1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26230240      PMCID： PMC4584252          DOI： 10.1164/rccm.201501-0082LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

1.  Functionally relevant thresholds of quadriceps femoris strength.

Authors:  Lori L Ploutz-Snyder; Todd Manini; Robert J Ploutz-Snyder; Douglas A Wolf
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-04       Impact factor: 6.053

2.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.

Authors:  J M Guralnik; E M Simonsick; L Ferrucci; R J Glynn; L F Berkman; D G Blazer; P A Scherr; R B Wallace
Journal:  J Gerontol       Date:  1994-03

3.  Relationship between knee extension force and stand-up performance in community-dwelling elderly women.

Authors:  D Corrigan; R W Bohannon
Journal:  Arch Phys Med Rehabil       Date:  2001-12       Impact factor: 3.966

Review 4.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

6.  Human skeletal muscle function: description of tests and normal values.

Authors:  R H Edwards; A Young; G P Hosking; D A Jones
Journal:  Clin Sci Mol Med       Date:  1977-03

7.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis.

Authors:  Samantha S C Kon; Jane L Canavan; Sarah E Jones; Claire M Nolan; Amy L Clark; Mandy J Dickson; Brigitte M Haselden; Michael I Polkey; William D-C Man
Journal:  Lancet Respir Med       Date:  2014-02-04       Impact factor: 30.700

8.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

Authors:  Miguel Divo; Claudia Cote; Juan P de Torres; Ciro Casanova; Jose M Marin; Victor Pinto-Plata; Javier Zulueta; Carlos Cabrera; Jorge Zagaceta; Gary Hunninghake; Bartolome Celli
Journal:  Am J Respir Crit Care Med       Date:  2012-05-03       Impact factor: 21.405

9.  Knee extension strength cutpoints for maintaining mobility.

Authors:  Todd M Manini; Marjolein Visser; Seok Won-Park; Kushang V Patel; Elsa S Strotmeyer; Hepei Chen; Bret Goodpaster; Nathalie De Rekeneire; Anne B Newman; Eleanor M Simonsick; Stephen B Kritchevsky; Kathy Ryder; Ann V Schwartz; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2007-03       Impact factor: 5.562

10.  Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation.

Authors:  Sarah E Jones; Matthew Maddocks; Samantha S C Kon; Jane L Canavan; Claire M Nolan; Amy L Clark; Michael I Polkey; William D-C Man
Journal:  Thorax       Date:  2015-01-05       Impact factor: 9.139
View more
  7 in total

1.  Longitudinal follow-up of quadriceps strength and function in a COPD cohort after 3 years.

Authors:  Sara C Buttery; Divya Mohan; Marie Fisk; Nicholas S Hopkinson; Ruth Tal-Singer; Ian B Wilkinson; Michael I Polkey
Journal:  Eur Respir J       Date:  2017-08-10       Impact factor: 16.671

Review 2.  Aspects of skeletal muscles in chronic respiratory disease.

Authors:  William D-C Man
Journal:  Chron Respir Dis       Date:  2016-08       Impact factor: 2.444

3.  Functionally Relevant Threshold of Quadriceps Muscle Strength in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Masahiro Iwakura; Masahiko Wakasa; Kazuki Okura; Atsuyoshi Kawagoshi; Keiyu Sugawara; Hitomi Takahashi; Takanobu Shioya
Journal:  Prog Rehabil Med       Date:  2021-02-06

Review 4.  Towards Personalized Management of Sarcopenia in COPD.

Authors:  Sophie I J van Bakel; Harry R Gosker; Ramon C Langen; Annemie M W J Schols
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-07

Review 5.  Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.

Authors:  Sarah Jones; William D-C Man; Wei Gao; Irene J Higginson; Andrew Wilcock; Matthew Maddocks
Journal:  Cochrane Database Syst Rev       Date:  2016-10-17

6.  Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study.

Authors:  Matthew Maddocks; Samantha S C Kon; Jane L Canavan; Sarah E Jones; Claire M Nolan; Alex Labey; Michael I Polkey; William D-C Man
Journal:  Thorax       Date:  2016-06-12       Impact factor: 9.139

7.  Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.

Authors:  Jilles M Fermont; Charlotte E Bolton; Marie Fisk; Divya Mohan; William Macnee; John R Cockcroft; Carmel McEniery; Jonathan Fuld; Joseph Cheriyan; Ruth Tal-Singer; Ian B Wilkinson; Angela M Wood; Michael I Polkey; Hana Müllerova
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.